- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06214728
Use of Hyaluronic Acid Gel in Intraosseous Defects
Assesment of Changes ın Clinical and Radiographic Parameters Following the Application of Local Hyaluronic acıd Gel as an Adjunct to Minimally Invasive Non-surgical Treatment of Intraosseous Defects
Aim:
The aim of this randomised, parallel-arm, blinded, controlled clinical trial was to compare the clinical and radiographic efficacy of MINST with and without 0.8% HA gel application in the treatment of intraosseous defects.
Research Hypothesis:
The null hypothesis that there is no statistically significant difference in clinical and radiographic measurements between the use of HA gel in addition to MINST for the treatment of intraosseous defects and MINST treatment alone was tested.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study was designed as a randomised controlled clinical trial and conducted between March 2022 and May 2023 at the Department of Periodontology, Bezmialem Vakıf University. Ethical approval was obtained from Clinical Research Ethics Committee of Bezmialem Vakıf University with approval number E.54753 on March 15, 2022.
The patients included in our study were selected from a total of 140 patients with complaints of gingival problems who applied to the Department of Periodontology at Bezmialem Vakıf University Faculty of Dentistry, specifically those having intraosseous defects in the premolar/molar teeth. Forty-two individuals were included in the study, and it was completed with a total of 36 participants, consisting of 25 females and 11 males.
Initial clinical periodontal measurements and periapical radiographs were taken from the defect area with parallel technique in the first session. Occlusal stents with fixed guide points were prepared to place the periodontal probe with the correct angle and inclination. During the initial session, complete oral supragingival calculus cleaning and oral hygiene motivation were performed. After that, patients were randomly assigned to the test (MINST + HA, n = 17) or control (MINST, n = 19) groups. Neither the patients nor the expert responsible for the clinical measurements (UGE) was aware of which treatment each individual had received.
The MINST concepts described by Nibali et al. were followed in the treatment protocol. During the procedure, a subpapillary approach was taken to reduce trauma to the soft tissues, particularly the papillae, using a 2.5x420 mm magnification loop . The instruments were gently placed within the periodontal pocket while the patient was under local anaesthesia , in order to keep the soft tissues stable. Using mini five curettes and ultrasonic devices with precise tips ,the root surfaces were cleaned reaching to the base of the pocket, avoiding excessive root surface smoothing and gingival curettage. The subgingival area was not irrigated to prevent deterioration of clot stabilisation during the wound healing process [1]. MINST was performed in all areas of the oral cavity with periodontal pockets >3 mm. The control group was treated with MINST alone without using any irrigation solution. Beside, in the test group, following MINST protocol same as in the control, HA gel was applied to the periodontal pockets where the intraosseous defect was located using a sterile injector with a plastic needle. The gel was applied until it overflowed from the gingival sulcus. Patients were instructed not to eat, drink or brush their teeth for at least one hour. Subgingival application of HA was repeated 4 weeks after the first session. The control group received placebo HA gel probe without rinsing.
Clinical examination Initial clinical measurements were taken by a single investigator (UGE) using the UNC15 probe at six sites on all teeth to determine the stage and grade of periodontitis in study population.
Clinical periodontal measurements of the defect site were recorded at baseline and repeated at 3 and 6 months following treatment. Probing depth (PD), clinical attachment level (CAL) and gingival recession (GR) measurements were made from two points including buccal and lingual area through a patient-specific acrylic stent in the defect area and recorded as average and deepest/worst. Bleeding on probing (BoP) and presence of plaque (P) were evaluated as present/absent in the buccal and lingual part of the defect area and recorded as %.
The gingival phenotype was evaluated by observing the probe's silhouette visibility using biotype probe located in the buccal point of the intraosseous defect area.
Pre-study investigator calibration was performed by repeating the PD and CAL measurements of 10 periodontitis patients who were not included in the study at 24 hours intervals. The intraclass correlation showed that the researcher's repeatability was at an acceptable level (PD; k-score: 0,817-0,952; CAL:0,836-0,926).
Radiographic examination For the diagnosis of intraosseous defects radiographs were taken at baseline and 6-month follow-up using a custom-made radiographic stent and the parallel cone technique. Radiographs were digitized and analysed by a single calibrated investigator using a computer software (Planmeca Romexis Viewer software). The radiographs were numbered prior to analysis to blind the analyst to the groups of radiographs. For investigator calibration, measurements of intraosseous defect depth (infra) and defect angle of periapical radiographs from 10 nonstudy patients were repeated at 24-hour intervals. Intra-class correlation coefficients ranging from 0.86 to 0.92 for the defect depth and angle measurements and it was determined that the reproducibility of the researcher was at an acceptable level. Radiographic measurements were made by using the reference points on tooth surface. Total defect depth (TDD): The distance from the cemento- enamel junction to the base of the defect (CEJ-DD) was measured. Intraosseous defect depth (INFRA): It is the distance from the projection of the alveolar crest point on the tooth to the bottom of the defect (DD). Distance from the CEJ to the alveolar crest (CEJ-BC): It is the distance from the projection of the alveolar crest point on the tooth and the cemento enamel junction (CEJ). Intra-osseous defect angle: The radiographic defect angle was measured between the CEJ-BD line of the involved tooth and the bone defect surface.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34000
- Bezmialem Vakıf University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of severe/progressed periodontitis (stage III/IV)
- Presence of an intraosseous defect with a probing depth ≥ 5 mm and defect depth ≥ 3 mm;
- Absence of furcation involvement,mobility and subgingival restoration in the vital tooth with intraosseous defect.
Exclusion Criteria:
- Systemic diseases
- Smokers
- Pregnant or lactating women
- Those who received periodontal treatment within the last 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: MINST
Minimally invasive non-surgical treatment (MINST): Using mini five curettes and ultrasonic devices with precise tips , the root surfaces were cleaned reaching to the base of the pocket, avoiding excessive root surface smoothing and gingival curettage.
|
The control group received placebo HA gel probe without rinsing.
Placebo application was repeated 4 weeks after the first session.
|
|
Active Comparator: MINST+HA
Minimally invasive non-surgical technique (MINST) with application of Hyaluronıc Acid gel: Using mini five curettes and ultrasonic devices with precise tips , the root surfaces were cleaned reaching to the base of the pocket, avoiding excessive root surface smoothing and gingival curettage.
HA gel was applied to the periodontal pockets where the intraosseous defect was located using a sterile injector with a plastic needle.
The gel was applied until it overflowed from the gingival sulcus.
|
HA gel was applied to the periodontal pockets where the intraosseous defect was located using a sterile injector with a plastic needle.
The gel was applied until it overflowed from the gingival sulcus.
Patients were instructed not to eat, drink or brush their teeth for at least one hour.
Subgingival application of HA was repeated 4 weeks after the first session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraosseous defect depth (INFRA)
Time Frame: Baseline - 6 months
|
It is the distance from the projection of the alveolar crest point on the tooth to the bottom of the defect (DD)
|
Baseline - 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Probing depth (PD)
Time Frame: Baseline - 3months - 6 months
|
as the measurement of the length between the bottom of the periodontal pocket to marginal gingiva
|
Baseline - 3months - 6 months
|
|
Clinical attachment level (CAL)
Time Frame: Baseline - 3months - 6 months
|
distance between the base of the pocket and the enamel cement junction
|
Baseline - 3months - 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gingival recession (GR)
Time Frame: Baseline - 3months - 6 months
|
as the measurement of the distance between the marginal gingiva and cemento-enamel junction
|
Baseline - 3months - 6 months
|
|
Bleeding on probing (BoP)
Time Frame: Baseline - 3months - 6 months
|
present/absent in the buccal and lingual part of the defect area and recorded as %.
|
Baseline - 3months - 6 months
|
|
Plaque (P)
Time Frame: Baseline - 3months - 6 months
|
present/absent in the buccal and lingual part of the defect area and recorded as %.
|
Baseline - 3months - 6 months
|
|
Total defect depth (TDD)
Time Frame: Baseline - 6 months
|
The distance from the cemento- enamel junction to the base of the defect (CEJ-DD) was measured.
|
Baseline - 6 months
|
|
Distance from the CEJ to the alveolar crest (CEJ-BC)
Time Frame: Baseline - 6 months
|
It is the distance from the projection of the alveolar crest point on the tooth and the cemento enamel junction (CEJ).
|
Baseline - 6 months
|
|
Intra-osseous defect angle
Time Frame: Baseline - 6 months
|
The radiographic defect angle was measured between the CEJ-BD line of the involved tooth and the bone defect surface
|
Baseline - 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Sadiye Gunpinar, Asc. Prof., Bezmialem Vakif University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UGUNDOGDU1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
Al-Azhar UniversityNot yet recruitingStage IV Periodontitis | Advanced Periodontitis | Stage III PeriodontitisEgypt
-
Azienda Socio Sanitaria Territoriale degli Spedali...Università degli Studi di FerraraCompletedPeriodontitis, Aggressive | Periodontitis, AdultItaly
-
University Hospital HeidelbergRecruitingPeriodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Stage IVGermany
-
Akdeniz UniversityNot yet recruitingPeriodontitis (Stage 3) | Periodontitis Stage IVTurkey (Türkiye)
-
Gülnur EmingilEge University Scientific Research Projects Coordination UnitCompletedPeriodontitis (Stage 3) | Periodontitis Stage IIITurkey (Türkiye)
Clinical Trials on Placebo gel application
-
Medical University of SilesiaRecruitingBruxism | Myofascial Pain | Temporomandibular Disorder | CBD | Orofacial PainPoland
-
Alexandria UniversityCompleted
-
Rabia AtillaNot yet recruitingThe Effect of Cold Packs on Hot Flushes and Depression in Women Going Through the Climacteric PeriodHot Flashes | Climactericum | Perimenopausal Depression | Cold Application | AcupointsTurkey (Türkiye)
-
Beth Israel Deaconess Medical CenterNot yet recruitingLabor Induction
-
Nancy MouradianInvicare Inc.CompletedPeri-implant Mucositis | Healthy Peri-implantCanada
-
IRCCS Policlinico S. DonatoB. Braun Milano SpANot yet recruitingSurgical Site Infection After Major SurgeryItaly
-
University of MessinaCompletedPeriodontal DiseasesItaly
-
Mennatullah osama ahmed zaki wahbaCompleted
-
Tarsus UniversityMustafa Kemal University; Mersin University; Necmettin Erbakan UniversityCompletedPerioperative Care | Healthy Individuals | Oxygen Saturation | Nursing | Gel NailTurkey